Press release
Irritable Bowel Syndrome (IBS) Treatment Market to Surpass USD 3.41 Billion by 2034
Irritable Bowel Syndrome (IBS) Treatment
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/48097
Key Takeaways
• Market Size (2024): USD 1.96 Billion
• Forecast (2034): USD 3.41 Billion
• CAGR (2025-2034): 5.8 %
• Key Segments: Type, Drug Class, Distribution Channel, Region
• Leading Companies: AbbVie Inc., Takeda Pharmaceutical Company Ltd., Bausch Health Companies Inc., Ardelyx Inc., Ironwood Pharmaceuticals Inc., Allergan plc, Alfasigma S.p.A., Astellas Pharma Inc., and Nestlé Health Science
Market Story
Irritable Bowel Syndrome (IBS) affects an estimated 10-15 % of the global population, characterized by chronic abdominal pain, bloating, and altered bowel habits. Historically undertreated, IBS management has evolved through the rise of gut-targeted pharmacotherapies, dietary interventions, and digital therapeutics.
Pharmaceutical companies are focusing on microbiome-modulating agents, serotonin-receptor modulators (5-HT3 and 5-HT4), and bile-acid blockers that address both IBS-C (constipation-predominant) and IBS-D (diarrhea-predominant) subtypes. Meanwhile, lifestyle-based programs such as low-FODMAP diet apps, stress-management platforms, and tele-gastroenterology consults are expanding the care ecosystem, reflecting a holistic shift from symptom relief to personalized disease control.
Market Segmentation
By Type: IBS-C (Constipation Predominant), IBS-D (Diarrhea Predominant), IBS-M (Mixed), IBS-U (Unsubtyped)
By Drug Class: Antispasmodics, Laxatives, Antidiarrheals, Serotonin Receptor Modulators, Probiotics & Microbiome Therapies, Others
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Region: North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Explore Full Report here: https://exactitudeconsultancy.com/reports/48097/irritable-bowel-syndrome-treatment-market
Recent Developments
• AbbVie Inc. received FDA clearance for Ibsrela® (tenapanor) to treat IBS-C with reduced systemic absorption and improved tolerability.
• Takeda Pharmaceutical expanded availability of Amitiza® and Motegrity® across emerging Asian markets.
• Ironwood Pharmaceuticals reported positive data on LINZESS® (linaclotide) in long-term symptom relief and quality-of-life improvements.
• Nestlé Health Science invested in microbiome-based probiotic research targeting gut-brain-axis signaling.
• Alfasigma S.p.A. launched Xifaxan® (rifaximin) lifecycle extensions to cover both IBS-D and hepatic encephalopathy indications.
Expert Insight
"IBS therapy is rapidly evolving from symptom suppression to microbiome re-balancing and neuromodulation. As personalized nutrition and AI-based tracking converge, the next generation of IBS treatment will be data-driven and preventive,"
- Lead Analyst, Exactitude Consultancy
Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=48097
Market Drivers
• Rising IBS Prevalence: Linked to urbanization, stress, and dietary changes.
• Microbiome Innovation: Probiotics and prebiotic-based therapies gaining regulatory traction.
• Patient Empowerment: Mobile apps and tele-gastroenterology improving disease management adherence.
• R&D Investments: Biologics and targeted receptor therapies entering Phase II/III pipelines.
Forecast & Regional Insights
North America dominates the market with over 42 % share (2024) due to advanced diagnostic capabilities and reimbursement support for specialty drugs. Europe follows with established dietary and psychological therapy frameworks. The Asia-Pacific region is anticipated to record the fastest CAGR of 6.6 %, driven by rising awareness, dietary transitions, and the growth of online pharmacy channels in India and China.
Conclusion
The Irritable Bowel Syndrome Treatment Market is on a transformative path-merging pharmacology with digital health and lifestyle medicine. As microbiome research and personalized care models expand, the coming decade will see IBS management evolve from reactive therapy to predictive, precision gastroenterology.
This report is also available in the following languages : Japanese (過敏性腸症候群の治療), Korean (과민성 대장 증후군 치료), Chinese (肠易激综合征治疗), French (Traitement du syndrome du côlon irritable), German (Behandlung des Reizdarmsyndroms), and Italian (Trattamento della sindrome dell'intestino irritabile), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/48097/irritable-bowel-syndrome-treatment-market#request-a-sample
Related Reports
Short Bowel Syndrome (SBS) Patient Pool Market
https://exactitudeconsultancy.com/reports/71165/short-bowel-syndrome-sbs-patient-pool-market
Irritable Bowel Syndrome (IBS) Patient Pool Analysis Market
https://exactitudeconsultancy.com/reports/71363/irritable-bowel-syndrome-ibs-patient-pool-analysis-market
Short Bowel Syndrome Market
https://exactitudeconsultancy.com/reports/71128/short-bowel-syndrome-market
Fecal Incontinence Market
https://exactitudeconsultancy.com/reports/71113/fecal-incontinence-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Irritable Bowel Syndrome (IBS) Treatment Market to Surpass USD 3.41 Billion by 2034 here
News-ID: 4259405 • Views: …
More Releases from Exactitude Consultancy
Cold Planer Market Sees Consistent Growth Supported by Global Road Rehabilitatio …
The global cold planer market is experiencing steady growth as governments and private contractors increase spending on road rehabilitation, resurfacing, and infrastructure modernization. Cold planers, also known as milling machines, are widely used to remove damaged asphalt and concrete surfaces efficiently, supporting sustainable road construction practices.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68250
Key Market Highlights
• Increasing focus on road maintenance and resurfacing projects
• Growing demand for efficient and precision milling…
Credit Management Software Market Accelerates as Organizations Focus on Risk Mit …
The global credit management software market is witnessing robust growth as organizations across industries adopt digital solutions to manage credit risk, improve receivables performance, and strengthen financial controls. Credit management software enables businesses to automate credit scoring, monitor customer creditworthiness, and streamline collections processes.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68248
Key Market Highlights
• Growing adoption of automated credit risk assessment tools
• Increasing focus on working capital and cash flow management
• Integration…
Session Border Controller Market Expands Rapidly as Enterprises and Telecom Oper …
The global session border controller (SBC) market is experiencing strong growth as telecom operators and enterprises increasingly deploy SBC solutions to secure, manage, and optimize real-time IP communications. SBCs play a critical role in protecting voice over IP (VoIP), unified communications (UC), and multimedia sessions from cyber threats while ensuring interoperability and quality of service.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68246
Key Market Highlights
• Growing adoption of VoIP and…
Biofuel Market Including E-Methane and Sustainable Aviation Fuel Gains Strong Tr …
The global biofuel market, encompassing e-methane, sustainable aviation fuel (SAF), and other advanced biofuels, is witnessing robust growth as governments and industries intensify efforts to reduce carbon emissions and transition toward cleaner energy sources. These fuels play a critical role in achieving net-zero targets while enabling decarbonization of hard-to-abate sectors such as aviation, shipping, and heavy transportation.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68244
Key Market Highlights
• Rapid growth of…
More Releases for IBS
Irritable Bowel Syndrome (IBS) Treatment Market Poised to Hit $7.68B by 2033 | S …
The Global Irritable Bowel Syndrome (IBS) Treatment Market reached US $3.61 billion in 2024 and is forecast to nearly double to US $7.68 billion by 2033, growing at a robust 8.8% CAGR from 2025 to 2033, according to DataM Intelligence's comprehensive report. IBS affects an estimated 5-10% of the global population, marking it one of the most prevalent gastrointestinal disorders with significant unmet medical needs.
👉 Download our latest market insights:…
IBS Implant Market Research Report 2023 - Valuates reports
The global IBS Implant market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
Get Sample report - https://reports.valuates.com/request/sample/QYRE-Auto-35O11417/Global_IBS_Implant_Market_Research_Report_2022
North American market for IBS Implant is estimated to increase from $ million in 2023 to reach $ million by 2029, at…
Integrated Bridge Systems Market Report 2018: Segmentation by Platform (Commerci …
Global Integrated Bridge Systems market research report provides company profile for Northrop Grumman Sperry Marine (U.K.), Raytheon Anschütz (Germany), Rolls Royce (U.K.), L-3 Communications Mapps Inc. (Canada), FURUNO Electric Shokai Ltd. (Japan) and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR…
IBS' solution to power China’s first Cruise Line
Trivandrum, 16 January 2013: Henna, the largest cruise ship in mainland China will run on IBS’ inventory and pricing management solution, Cruise Partner, when it makes its maiden journey on January 26, 2013. China based HNA Tourism Cruise and Yacht Management Company unveiled this cruise ship on November 28, 2012. Henna has 739 rooms for 1,965 passengers, as well as a complete range of facilities for living and entertainment. HNA…
Vikash Sureka joins IBS as Chief Financial Officer
Trivandrum (India), 17 May 2012: IBS Software Services, the leading provider of new-generation IT solutions to the global aviation industry, has appointed Mr Vikash Sureka as its Chief Financial Officer. He will head the Finance, Legal, Company Affairs and Administration functions of IBS operations world-wide.
A Chartered Accountant, Vikash has over 19 years of experience mostly in senior executive roles managing business globally with proven proficiency in Investor Relations, P&L…
Raytheon Anschütz IBS for new Intership Bulkers
Raytheon Anschütz was recently awarded a contract to supply their Integrated Bridge System (IBS) to two new bulk carriers. The bulkers will be built at New Times Shipyard in Jingjiang, China. The delivery to the Cyprus based shipping company Intership Navigation Co. Ltd., a member of the German Hartmann Group, is scheduled for August and October 2011.
The new bulkers, each with a capacity of 176,000 dwt, will be equipped…
